JOURNAL ARTICLE
Extravasation and infiltration: under-recognised complications of intravenous therapy.
Published In: British Journal of Nursing, 2024, v. 33. P. S4 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Barton, Andrew 3 of 3
Abstract
Occasionally, the administration of intravenous (IV) therapies can go wrong. Infiltration or extravasation is a complication when a drug or IV therapy leaks into the tissues surrounding the vascular access device. Extravasation can cause serious and often life-changing injuries. Extravasation is often associated with systemic anti-cancer therapy but non-chemotherapy drugs have been reported as having a greater risk of serious complications. This study outlines the first UK Infusion unit evaluation of the ivWatch infusion monitoring device which was undertaken from August 2023 to January 2024. Out of 2254 infusions monitored with ivWatch, the device prevented 122 cases of infiltration and extravasation from causing any harm to the patient, corresponding to a 5.4% 'check IV' notification rate. [ABSTRACT FROM AUTHOR]
Additional Information
- Source:British Journal of Nursing. 2024/04, Vol. 33, pS4
- Document Type:Article
- Subject Area:Health and Medicine
- Publication Date:2024
- ISSN:0966-0461
- DOI:10.12968/bjon.2024.33.Sup7.S4
- Accession Number:185128974
- Copyright Statement:Copyright of British Journal of Nursing is the property of Mark Allen Holdings Limited and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.